Dear Mats,

thank you, that is exactly what I am trying now (as I have IIV on central 
volume). I will now only include the diagonal elements of the omega 
matrix, and have included the correlation in the thetas as CL/F.
Let's see how this works.
One question out of curiosity: I know that in a one-compartment model, 
NONMEM would not be able to differentiate between IIV on volume or IIV on 
F1. But with more compartments, this should work, shouldn't it, even if I 
only have oral data?

Best wishes
Nele
______________________________________________________________

Dr. Nele Plock
Pharmacometrics -- Modeling and Simulation

Nycomed GmbH
Byk-Gulden-Str. 2
D-78467 Konstanz, Germany

Fon: (+49) 7531 / 84 -  4759
Fax: (+49) 7531 / 84 - 94759

mailto: nele.pl...@nycomed.com
http://www.nycomed.com

County Court: Freiburg, Commercial Register HRB 701257
Chairman Supervisory Board: Charles Depasse
Management Board: Dr. Barthold Piening, Gilbert Rademacher, Dr. Anders 
Ullman




mats.karls...@farmbio.uu.se 
16.04.2009 09:05

To
drmo...@pri-home.net, Nele Plock/DEKON/AP/alt...@altana-mail, 
nmusers@globomaxnm.com
cc

Subject
RE: [NMusers] OMEGA BLOCK with mixture model?






Hi Diane,
 
With oral data only I would normally model with BLOCK(2) on CL/F and V/F 
or a DIAG(3) on CL/F, V/F and relative F. The latter may have some 
advantages for diagnostics, covariate model building etc. Also, if the 
underlying model truly is a mixture model on F, it could be parsimonious, 
needing mixture only one parameter only. You can’t have IIV on CL, V and 
relF + off-diagonal elements without overparameterizing the model. 
However, although I have never tried it, I guess that a BLOCK(2) on CL and 
relative F could work, provided you have no ETA on V. If you also have an 
ETA on V all the problems you mention would be realized. I don’t know if 
Nele has IIV on V, but if so, she should definitely reduce IIV model size. 
With respect to the mixture model, maybe it is possible to reparameterize 
such that the mixture component only concerns one ETA.
 
Best regards,
Mats
 
Mats Karlsson, PhD
Professor of Pharmacometrics
Dept of Pharmaceutical Biosciences
Uppsala University
Box 591
751 24 Uppsala Sweden
phone: +46 18 4714105
fax: +46 18 471 4003
 
From: Diane R Mould [mailto:drmo...@attglobal.net] 
Sent: Wednesday, April 15, 2009 6:16 PM
To: 'Mats Karlsson'; nele.pl...@nycomed.com; nmusers@globomaxnm.com
Subject: RE: [NMusers] OMEGA BLOCK with mixture model?
 
Dear All
 
I am not sure if this topic has been covered before or not, but as its 
related to the question below, I thought I would bring it up again.
 
I have to wonder at the appropriateness of including the IIV term for F in 
an omega BLOCK structure in the first place?  I can certainly understand 
estimating relative bioavailability and even estimating the associated 
variability for F, although there are often estimatability issues for an 
IIV term for F, even with IV data to help estimate F (or at least using a 
reference value for F like one formulation or one occasion). 
 
However because with orally administered drugs, CL is really CL/F then 
there is an inherent correlation between CL and F.  With F and CL, this 
correlation is really in the THETA values so that if the model captures 
the correlation at the THETA level, ie allow for larger clearance with 
larger F (or vice versa), then the random effects for F and CL may be 
uncorrelated.  However, if the population model does not capture that 
correlation at the THETA level, then correlation will be captured via the 
random effects, possibly resulting in an over-parameterized OMEGA matrix. 
As this latter situation seems to be very common (e.g. that the 
correlation between F and CL etc is picked up in the etas) then one might 
expect to see high condition numbers, zero gradients etc when IIV on F is 
added to the omega BLOCK structure.
 
I would guess that as a rule, its probably more appropriate to keep the 
IIV term for F out of a BLOCK structure.  Can anybody comment on this?
 
Best regards,
Diane
 

From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] 
On Behalf Of Mats Karlsson
Sent: Tuesday, April 14, 2009 2:08 PM
To: nele.pl...@nycomed.com; nmusers@globomaxnm.com
Subject: RE: [NMusers] OMEGA BLOCK with mixture model?
 
Dear Nele,
 
I think you may want to reconsider your model. If you have a negative 
correlation between CL and F1, it is likely to be related to high 
presystemic metabolism (first-pass) effect. If so, it seems strange to 
assume that the F1 distribution would not change between the two 
subpopulations. I think you need to have separate CL as well as F1 for the 
two subpopulations. Thus I would have CL and F1 described by ETA(1) and 
ETA(2) for subpopulation 1 and CL and F1 described by ETA(3) and ETA(4) 
for the second subpopulation.  If hepatic elimination is responsible for 
the correlation, it is probably more parsimonious to use a 
semi-mechanistic model with a hepatic compartment (with a single ETA for 
variation in metabolic activity). Two examples of implementations of a 
separate hepatic compartment are :
Piotrovskij et al. Pharm Res. 1997 Feb;14(2):230-7.
Gordi et al., Br J Clin Pharmacol. 2005 Feb;59(2):189-98
 
Best regards,
Mats
 
 
Mats Karlsson, PhD
Professor of Pharmacometrics
Dept of Pharmaceutical Biosciences
Uppsala University
Box 591
751 24 Uppsala Sweden
phone: +46 18 4714105
fax: +46 18 471 4003
 
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] 
On Behalf Of nele.pl...@nycomed.com
Sent: Tuesday, April 14, 2009 5:09 PM
To: nmusers@globomaxnm.com
Subject: [NMusers] OMEGA BLOCK with mixture model?
 

Dear all, 

I am trying to fit a PK model to oral data. In the data, we observed two 
things: First, CL seems to be negatively correlated with F1. Secondly, 
there seem to be two subpopulations in the exposure, let's say a large 
group with 'normal' and a second group with high exposure. I would like to 
identify the subpopulations using a mixture model, but keep the 
correlation between CL and F1. Now I ran into problems when coding the 
$OMEGA BLOCK. 

I figured the block to be something like: 
$OMEGA BLOCK(3) 
0.1  ;CL1 
0 FIX 0.1 ;CL2 
0.01 0.01 0.1 ;F1 

The error message that appears is: 
a covariance is zero, but the block is not a band matrix 

I assume that this means that I am not allowed to fix the correlation 
between the two clearance-omegas to zero. However, it would be 
unreasonable to allow a correlation, because the omegas belong to 
different subpopulations, so there can't be a correlation. On the other 
hand, I did not include subpopulations for F1, so how can I keep this 
correlation to both CL-subgroups? 

Any thoughts on this would be highly appreciated! 
Best wishes 
Nele 
______________________________________________________________

Dr. Nele Plock
Pharmacometrics -- Modeling and Simulation

Nycomed GmbH
Byk-Gulden-Str. 2
D-78467 Konstanz, Germany

Fon: (+49) 7531 / 84 -  4759
Fax: (+49) 7531 / 84 - 94759

mailto: nele.pl...@nycomed.com
http://www.nycomed.com

County Court: Freiburg, Commercial Register HRB 701257
Chairman Supervisory Board: Charles Depasse
Management Board: Dr. Barthold Piening, Gilbert Rademacher, Dr. Anders 
Ullman
 
 
 
 
 
----------------------------------------------------------------------
Proprietary or confidential information belonging to Nycomed Group may
be contained in this message. If you are not the addressee indicated
in this message, please do not copy or deliver this message to anyone.
In such case, please destroy this message and notify the sender by
reply e-mail. Please advise the sender immediately if you or your
employer do not consent to Internet e-mail for messages of this kind.
Opinions, conclusions and other information in this message that
pertain to the sender's employer and its products and services
represent the opinion of the sender and do not necessarily represent
or reflect the views and opinions of the employer.
----------------------------------------------------------------------






----------------------------------------------------------------------
Proprietary or confidential information belonging to Nycomed Group may
be contained in this message. If you are not the addressee indicated
in this message, please do not copy or deliver this message to anyone.
In such case, please destroy this message and notify the sender by
reply e-mail. Please advise the sender immediately if you or your
employer do not consent to Internet e-mail for messages of this kind.
Opinions, conclusions and other information in this message that
pertain to the sender's employer and its products and services
represent the opinion of the sender and do not necessarily represent
or reflect the views and opinions of the employer.
----------------------------------------------------------------------

Reply via email to